PanaMa

Randomized phase II study for evaluation of efficacy and safety of maintenance treatment with 5-FU/FA plus panitumumab vs. 5-FU/FA alone after prior induction treatment with mFOLFOX6 plus panitumumab and re-induction with mFOLFOX6 plus panitumumab in case of progression for first-line treatment of patients with metastatic colorectal cancer

II

Status: Rekrutierung beendet

Zeitraum

2014

2021

Zentren

98

Keine Zentren gesucht

Patienten

387

14.04.2022

Beteiligte

AIO-Arbeitsgruppen

Identifier

AIO-KRK-0212

Kontakt

Leitung

Prof. Dr. med. Dominik Paul Modest